Skip to main content
Clinical Trials/NCT01422278
NCT01422278UnknownPhase 1

Patients With Conversion Gait Disorder - Effect on Treatment and Common Gait Patterns. Randomized Clinical Trial

Oslo University Hospital2 sites in 1 country60 target enrollmentStarted: September 1, 2007Last updated:
Conditions

Trial Snapshot

Phase
Phase 1
Sponsor
Enrollment
60
Locations
2
Primary Endpoint
Change in gait patterns

Study Overview

Brief Summary

Evaluating the effects in functional status after three weeks of cognitive - and behavioural rehabilitation on patients with gait disorder. The patients are followed up as after 1 and 12 months to study if any improvement is still present. The patients are being recruited from neurological units. The intervention is explanation of symptoms, positive reinforcement of normal behaviour and absence reinforcement of dysfunctional behaviour. In addition the study aims at describing typical gait patterns at patients with gait disorder by using biomechanical measurements (EKG).

Detailed Description

Patients are being recruited from neurological unit/ div and out patients department of SSR and are randomized to treatment or control group. Essential gait disorders do to conversion symptoms and willingness to participate in either of the two groups with informed consent are required.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Crossover
Primary Purpose
Treatment
Masking
Single (Participant)

Eligibility Criteria

Ages
18 Years to 69 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • To determine the changes in functional status after three weeks of multidisciplinary rehabilitation in patients with conversion walking disorder.

Exclusion Criteria

  • Essential gait disorders do to conversion symptoms and willingness to participate in either of the two groups with informed consent are required.

Outcomes

Primary Outcomes

Change in gait patterns

Time Frame: three weeks

Secondary Outcomes

  • Improved life quality(12 months)

Investigators

Sponsor
Oslo University Hospital
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Annika A. Jordbru

PhD student

Oslo University Hospital

Study Sites (2)

Loading locations...

Similar Trials